Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entity

Enliven Therapeutics

Tracked across 1 events · 7 articles · First seen Jun 11, 2026 · Last active Jun 12, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 20
Business
Enliven Therapeutics, a clinical-stage biopharmaceutical company, announced the pricing of its upsized underwritten public offering. The offering includes 8,933,334 shares of common stock at $37.50 per share and 1,733,333 pre-funded warrants at $37.499 per warrant.…
Impact: Enliven Therapeutics is the company conducting the public offering of its common stock and pre-funded warrants to raise approximately $400.0 million in gross proceeds, which will provide capital for its operations and development of small molecule therapeutics.
Jun 11, 2026 · 7 articles
NEWSDESK
Track Enliven Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.